Literature DB >> 12586108

The anti-proliferative activity of interferon-gamma on ovarian cancer: in vitro and in vivo.

L Wall1, F Burke, J F Smyth, F Balkwill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12586108     DOI： 10.1006/gyno.2002.6707

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  11 in total

1.  Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma.

Authors:  Jo Eyles; Anne-Laure Puaux; Xiaojie Wang; Benjamin Toh; Celine Prakash; Michelle Hong; Tze Guan Tan; Lin Zheng; Lai Chun Ong; Yi Jin; Masashi Kato; Armelle Prévost-Blondel; Pierce Chow; Henry Yang; Jean-Pierre Abastado
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

Review 2.  Effects of Physical, Chemical, and Biological Stimulus on h-MSC Expansion and Their Functional Characteristics.

Authors:  David A Castilla-Casadiego; Ana M Reyes-Ramos; Maribella Domenech; Jorge Almodovar
Journal:  Ann Biomed Eng       Date:  2019-11-08       Impact factor: 3.934

3.  PEGylation improves the pharmacokinetic properties and ability of interferon gamma to inhibit growth of a human tumor xenograft in athymic mice.

Authors:  Christine M Fam; Stephen P Eisenberg; Sharon J Carlson; Elizabeth A Chlipala; George N Cox; Mary S Rosendahl
Journal:  J Interferon Cytokine Res       Date:  2014-05-19       Impact factor: 2.607

4.  Pan-Cancer Survey of Tumor Mass Dormancy and Underlying Mutational Processes.

Authors:  Anna Julia Wiecek; Daniel Hadar Jacobson; Wojciech Lason; Maria Secrier
Journal:  Front Cell Dev Biol       Date:  2021-07-09

5.  Interferon gamma induces protective non-canonical signaling pathways in primary neurons.

Authors:  Lauren A O'Donnell; Kristen M Henkins; Apurva Kulkarni; Christine M Matullo; Siddharth Balachandran; Anil K Pattisapu; Glenn F Rall
Journal:  J Neurochem       Date:  2015-08-31       Impact factor: 5.372

Review 6.  The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade.

Authors:  Lana E Kandalaft; Nathan Singh; John B Liao; Andrea Facciabene; Jonathan S Berek; Daniel J Powell; George Coukos
Journal:  Gynecol Oncol       Date:  2009-12-02       Impact factor: 5.482

Review 7.  Clinical Use of Interferon-gamma.

Authors:  Catriona H T Miller; Stephen G Maher; Howard A Young
Journal:  Ann N Y Acad Sci       Date:  2009-12       Impact factor: 5.691

8.  A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB.

Authors:  Inès Souissi; Imen Najjar; Laurent Ah-Koon; Pierre Olivier Schischmanoff; Denis Lesage; Stéphanie Le Coquil; Claudine Roger; Isabelle Dusanter-Fourt; Nadine Varin-Blank; An Cao; Valeri Metelev; Fanny Baran-Marszak; Remi Fagard
Journal:  BMC Cell Biol       Date:  2011-04-12       Impact factor: 4.241

9.  The antiviral cytokine interferon-gamma restricts neural stem/progenitor cell proliferation through activation of STAT1 and modulation of retinoblastoma protein phosphorylation.

Authors:  Apurva Kulkarni; Taylor J Scully; Lauren A O'Donnell
Journal:  J Neurosci Res       Date:  2016-11-15       Impact factor: 4.164

10.  Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.

Authors:  Tiziana de Cristofaro; Tina Di Palma; Amata Amy Soriano; Antonella Monticelli; Ornella Affinito; Sergio Cocozza; Mariastella Zannini
Journal:  Oncotarget       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.